Laura Tan, Ph.D.
About Laura Tan, Ph.D.
Laura Tan, Ph.D., is a Principal Scientist at Alkermes in the United States, with extensive experience in neuroscience research, particularly focusing on corticotropin-releasing factor (CRF) and its role in stress-related disorders.
Current Role at Alkermes
Laura Tan, Ph.D., currently holds the position of Principal Scientist at Alkermes, a prominent biotechnology company in the United States. Her role involves contributing to the development of innovative therapies aimed at addressing central nervous system disorders, including psychiatric conditions and neurological diseases.
Previous Roles at Alkermes
Between 2017 and 2022, Laura Tan served as a Senior Scientist at Alkermes in Waltham, MA. During her 5-year tenure in this role, she was involved in various research and development projects aimed at creating effective treatments for central nervous system conditions. Her work was focused on exploring novel therapeutic targets and mechanisms.
Academic and Research Background
Laura Tan has an extensive academic background in Neuroscience, having earned her Ph.D. from the University of Toronto. Her doctoral research was centered on understanding the role of corticotropin-releasing factor (CRF) in stress-related neurological and metabolic disorders. She also holds an Hon. B.Sc. in Zoology/Animal Biology from the same institution.
Postdoctoral Experience at Salk Institute
From 2011 to 2017, Laura Tan worked as a Postdoctoral Research Associate at the Salk Institute for Biological Studies in the Greater San Diego Area. Her research during this period was focused on the role of newly-discovered peptides that regulate the effects of CRF and their potential therapeutic applications for Alzheimer's disease and psychiatric disorders.
Research Interests and Contributions
Laura Tan's research is primarily focused on how CRF mediates behavioral responses to stress and identifying therapeutic targets within the CRF system to address stress-related disorders. Her work aims to develop novel therapeutics that can better manage stress-related neurological and psychiatric conditions. She also actively participates in initiatives that create opportunities for women in STEM.